NCT01870388View on ClinicalTrials.gov

A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Liver DiseasesHepatic Insufficiency
Interventions
DRUG

Baricitinib

Administered orally

Trial Locations (2)

32806

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Orlando

33014

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Miami

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01870388 - A Pharmacokinetic Study of Baricitinib in Participants With Liver Disease | Biotech Hunter | Biotech Hunter